Organon & Co. (OGN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Organon & Co..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.533 -- 00:00:06.979 Hello and welcome to the Organon fourth quarter and full year 2025 earnings 00:00:06.979 -- 00:00:12.685 call and webcast. All lines have been placed on mute to prevent any background noise. 00:00:12.685 -- 00:00:16.770 After the speaker's remarks, there will be a question and answer session, and if you 00:00:16.770 -- 00:00:20.995 would like to ask a question during this time, please press star one on your telephone 00:00:20.995 -- 00:00:22.496 keypad. 00:00:22.496 -- 00:00:27.041 I would now like to turn the conference over to Jennifer Halczak, Vice President, Investor 00:00:27.041 -- 00:00:29.461 Relations. You may begin. 00:00:29.461 -- 00:00:31.585 Thank you, Operator. Good morning, everyone. 00:00:31.585 -- 00:00:36.193 With me today are Joe Morrissey, Organon's Interim Chief Executive Officer, and Matt 00:00:36.193 -- 00:00:41.222 Walsh, our Chief Financial Officer. Carrie Cox, Organon's Board Chair, and 00:00:41.222 -- 00:00:46.071 Juan Camilo Arrona-Ferreira, Organon's Head of R&D, will also be joining for the Q&A 00:00:46.071 -- 00:00:50.939 portion of this call. Today, we are referencing a presentation that will be visible during 00:00:50.939 -- 00:00:53.609 this call for those of you on our webcast. 00:00:53.609 -- 00:00:57.814 This presentation will also be available following this call on the events and presentation 00:00:57.814 -- 00:01:01.077 section of our Organon investor relations website. 00:01:01.077 -- 00:01:05.282 Please reference slides two and three for a couple of brief reminders. 00:01:05.282 -- 00:01:08.925 I would like to caution listeners that certain information discussed by management during 00:01:08.925 -- 00:01:11.849 this call will include forward-looking statements. 00:01:11.849 -- 00:01:16.093 F...